The FDA approved Biogen’s Alzheimer’s drug last year even as a panel of outside medical experts expressed concerns about its efficacy. Read More
We współpracy z: https://fortune.com/2022/12/29/congress-report-fda-approval-biogen-aduhelm-alzheimers/
JPMorgan drops suit against Tesla over Musk tweet, warrants
„JPMorgan and Tesla have decided to enter into a new commercial relationship and settle the outstanding disputes between…
